Tekla Capital Management’s Inspire Medical Systems INSP Stock Holding History

Tekla Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$7.15M	Buy	+22,018	New	+$6.29M	0.28%	69

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Tekla Capital Management's INSP Position: Q2 2023 in Review

Tekla Capital Management opened a new position in Inspire Medical Systems (INSP) in Q2 2023: 22,018 shares worth $7.15M. The stake represents 0.28% of the portfolio and ranks #69 among its holdings.

407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

Tekla Capital Management held 22,018 shares of Inspire Medical Systems worth $7.15M as of Q2 2023.
Inspire Medical Systems was a new Tekla Capital Management position in Q2 2023.
Inspire Medical Systems made up 0.28% of Tekla Capital Management's portfolio in Q2 2023, its #69 holding.
407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.